期刊
JACC-CARDIOVASCULAR INTERVENTIONS
卷 13, 期 19, 页码 2208-2216出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2020.06.037
关键词
cardiogenic shock; lactate clearance; myocardial infarction; prognosis; serum lactate
资金
- German Research Foundation (Bonn, Germany)
- German Heart Research Foundation (Frankfurt, Germany)
- German Cardiac Society (Dusseldorf, Germany)
- Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (Berlin, Germany)
- University of Leipzig Heart Center (Leipzig, Germany)
- Maquet Cardiopulmonary (Rastatt, Germany)
- Teleflex Medical (Wayne, Pennsylvania)
OBJECTIVES This study sought to compare single lactate values at admission (L1) and after 8 h (L2) with lactate clearance (LC) for mortality prediction in cardiogenic shock (CS). BACKGROUND Early estimation of prognosis in CS complicating acute myocardial infarction is crucial for tailored treatment selection. Arterial lactate is the most widely used point-of-care parameter in CS. In septic shock, lactate reduction over time-LC-has been extensively investigated. However, in CS, only limited data exist, and the prognostic value of LC is unknown. METHODS This study is a subanalysis of the IABP-SHOCK II (Intraaortic Balloon Pump in Cardiogenic Shock II) trial and the corresponding registry. Lactate levels were prospectively collected. All-cause mortality at 30 days was assessed as primary endpoint. RESULTS For 671 of 783 (85.7%) patients, L1 and L2 values were available. The area under the receiver-operating characteristic curve (L1: 0.69; L2: 0.76; LC: 0.59) showed no difference between L1 and LC (p = 0.20). In contrast, L2 was a significantly better predictive parameter than L1 or LC (p < 0.001 for both). In multivariable stepwise Cox regression analysis, L2 $3.1 mmol/l (best cutoff value by Youden index) and LC <-3.45%/h remained independently predictive for time to death (p < 0.001 for both), with L2 showing the highest chi-square test score (42.1) and hazard ratio (2.89; 95% confidence interval: 2.10 to 3.97). CONCLUSIONS Arterial lactate after 8 h is superior in mortality prediction in comparison with baseline lactate and LC. A cutoff value of 3.1 mmol/l for lactate after 8 h showed the best discrimination for assessing early prognosis in CS and may serve as new treatment goal. (C) 2020 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据